Aug 5, 2026 04:05PM
Aug 3, 2026 08:00AM
Aug 3, 2026 08:00AM
Jun 30, 2026 08:02AM
Jun 30, 2026 08:00AM
Jun 10, 2026 08:02AM
Jun 10, 2026 08:00AM Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio
May 7, 2026 07:00AM
May 4, 2026 08:04AM
May 4, 2026 08:00AM
Apr 14, 2026 10:59AM
Apr 13, 2026 08:03AM
Apr 13, 2026 08:00AM
Apr 1, 2026 04:05PM Akebia Therapeutics names Philip Vickers to board of directors
Apr 1, 2026 04:05PM
Mar 19, 2026 04:05PM
Feb 26, 2026 07:00AM
Jan 12, 2026 08:02AM
Jan 12, 2026 08:00AM
Jan 6, 2026 08:01AM
Jan 6, 2026 08:00AM Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)
Dec 1, 2025 07:00AM
Nov 10, 2025 07:00AM
Nov 6, 2025 06:30PM
Oct 28, 2025 04:30PM
Oct 28, 2025 04:30PM
Oct 20, 2025 08:08AM
Aug 21, 2025 08:01AM Akebia expands Vafseo access through IRC's 230 dialysis centers
Aug 21, 2025 08:00AM
Aug 7, 2025 07:00AM
Aug 4, 2025 08:00AM
Jun 4, 2025 08:01AM
Jun 4, 2025 08:00AM
May 8, 2025 07:00AM
Apr 3, 2025 08:01AM Akebia Therapeutics (AKBA) Announces Positive Opinion of European Medicines Agency for XOANACYL
Apr 3, 2025 08:00AM
Mar 13, 2025 07:00AM
Jan 13, 2025 08:06AM
Jan 13, 2025 08:00AM
Dec 3, 2024 07:00AM
Nov 14, 2024 08:00AM
Nov 7, 2024 07:00AM Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Oct 22, 2024 08:03AM
Oct 22, 2024 08:00AM
Oct 15, 2024 08:00AM
Oct 11, 2024 06:37AM
Oct 10, 2024 08:02AM
Oct 10, 2024 08:00AM
Oct 8, 2024 06:49AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)
Oct 7, 2024 08:05AM

328,149 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All